tranexamic acid has been researched along with erbium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdallah, N; Agamia, N; Otb, S; Sadek, A; Shaarawy, E; Soliman, M; Tawfik, AA | 1 |
| Asilian, A; Bahrami, B; Faghihi, G; Iraji, F; Mokhtari, F | 1 |
| Botsali, A; Caliskan, E; Erbil, H; Esme, P | 1 |
1 trial(s) available for tranexamic acid and erbium
| Article | Year |
|---|---|
Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
Topics: Erbium; Female; Humans; Hydroquinones; Lasers, Solid-State; Melanosis; Tranexamic Acid; Treatment Outcome | 2022 |
2 other study(ies) available for tranexamic acid and erbium
| Article | Year |
|---|---|
A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
Topics: Erbium; Humans; Lasers, Solid-State; Melanosis; Tranexamic Acid; Treatment Outcome | 2022 |
Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma.
Topics: Erbium; Humans; Lasers, Solid-State; Melanosis; Retrospective Studies; Tranexamic Acid; Treatment Outcome | 2022 |